Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine

Figure 4

Docking poses of the ligands with CDK2 binding sites. (a) Tetrahydropalmatine, (b) Reserpiline, (c) (+)-Corydaline, and (d) Dinaciclib.

(a)

(b)

(c)

(d)